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INTRODUCTION
Bloody	milk	 or	 hemolactia	 in	 lactating	 dairy	
cattle	 is	 relatively	 common	 in	 both	 heifers	 and	
multiparous	cows	(George	et al.,	2008;	Radostits	
et al.,	 2007).	 Although	 the	 condition	 occurs	
sporadically,	 in	 certain	 geographic	 locations	 an	
incidence	rate	of	over	50%	has	been	reported	 in	
some	herds	 (George	et al.,	 2008;	Radostits	et al.,	
2007).	In	heifers,	the	condition	is	more	commonly	
associated	 with	 severe	 udder	 edema	 around	
parturition.	 In	 multiparous	 cows,	 the	 condition	
is	 usually	 due	 to	 self-inflected	 trauma,	 trauma	
due	to	other	cows	kicking	the	udder	or	awkward	
posture	during	recumbency	(George	et al.,	2008;	
Radostits	 et al.,	 2007).	 Thrombocytopenia	 has	
been	 documented	 in	 some	 cases	 but	 the	 exact	
role	 of	 this	 condition	 has	 not	 been	 elucidated	
yet	 (George	 et al.,	 2008;	 Radostits	 et al.,	 2007).	
Although,	 severe	 bleeding	 to	 cause	 hemorrhagic	
shock	 is	 not	 common,	 treatment	 in	 prolonged	
cases	 is	 requested	 because	 of	 the	 loss	 of	 milk	
production.	In	cattle	with	hemolactia,	intravenous	
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Abstract
This	study	was	carried	out	 to	evaluate	the	safety	and	efficacy	of	 intravenous	 injection	of	500-ml	of	0.37%	
formalin	as	a	treatment	of	hemolactia	not	associated	with	physiologic	udder	edema	in	dairy	cattle.	Fifteen	adult	
lactating	Holstein	dairy	cows	suffering	from	hemolactia	in	one	or	more	quarters	were	used.	Another	10	cows	with	
hemolactaia	were	not	 treated	and	used	as	a	 control.	Cows	were	 subjected	 to	a	 complete	physical	 examination	
before	administration	and	daily	for	7	days	thereafter.	Hematology,	serum	biochemistry,	and	the	coagulation	times	
(prothrombin	time,	activated	partial	thromboplastin	time	and	thrombin	time)	in	addition	to	D-dimers,	fibrinogen	
concentration	and	platelets	counts	were	evaluated	before	injection	and	1	week	after	the	last	injection.	Cows	were	
followed-up	for	12	months	after	the	end	of	treatment	for	long-term	side	effects.	Approximately	eighty-one	percent	
(81.25%)	of	affected	quarters	were	cured	 in	an	average	of	4	days	 in	 the	 formalin-treated	cows	while	 less	 than	
50%	of	cows	that	were	not	treated	cured	in	approximately	7	to	8	days.	There	were	no	clinical,	hematological	or	
serum	biochemical	abnormalities	associated	with	the	injection	of	the	drug.	Platelets	numbers	were	significantly	
increased	and	the	activated	partial	thromboplastin	clotting	times	(APTT)	was	significantly	decreased	in	treated	
cows	at	1	week	after	the	last	injection.	Results	of	this	study	prove	safe	and	effective,	yet	widely	available	and	cheap	
treatment	for	dairy	cows	affected	with	hemolactia.	This	treatment	will	prevent	significant	production	losses	due	to	
discard	of	unfit	for	human	consumption	bloody	milk.
Keywords: bloody milk, coagulation, formalin, hemolactia, mastitis
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administration	 of	 calcium	 borogluconate	 and	
some	parenteral	coagulants	have	been	tried	for	the	
treatment	of	this	condition	but	scientific	evidence	
of	their	safety	and	efficacy	is	lacking	(Ayaz,	1999;	
Eddy	and	Clark,	1982;	Muhammad	et al.,	1997).	
In	 horses,	 severe	 acute	 hemorrhage	 due	 to	
trauma,	rupture	of	the	uterine	artery	and	epistaxis	
are	considered	life-threatening	emergencies	(Jones,	
1998;	Santschi,	1999;	Taylor	et al.,	2000).	Moreover,	
in	 human	medicine,	 intractable	 hemorrhage	 from	
the	 urinary	 bladder	 and	 rectum	 associated	 with	
inflammatory,	 ulcerative	 or	 tumorous	 conditions	
present	great	challenges	 for	 the	clinician	(Choong	
et al.,	 2000;	 Lee	 et al.,	 2007;	 Manikandan	 et al.,	
2010).	 Topical	 and	 intralesional	 injection	 of	
formalin	 as	 a	 pro-coagulant	 has	 been	 tried	 treat	
intractable	hemorrhage	in	dogs,	horses	and	human	
beings	with	promising	success	(Choong	et al.,	2000;	
Henrikson	et al.,	2004;	Kang	et al.,	2003;	Lee	et al.,	
2007;	Mathai	et al.,	 1995;	Mohamed	et al.,	 2012).	
However,	 the	 safety	 and	 efficacy	 of	 intravenous	
injection	 of	 formalin	 to	 dairy	 cattle	 affected	with	
hemolactia	 was	 evaluated	 here	 for	 the	 first	 time.	
This	may	present	a	new	and	innovative,	yet	cheap	
treatment	of	this	common	condition.	
MATERIALS AND METHODS 
Animals
All	 procedures	 and	 protocols	 used	 in	 this	
study	 were	 approved	 by	 the	 animal	 care	 and	
use	 committee	 of	 Jordan	 University	 of	 Science	
and	 Technology	 (ACUC-JUST).	 The	 owner	 of	 the	
dairy	 farm	from	which	animals	were	used	 in	 the	
study	 signed	 a	 written	 consent.	 The	 study	 was	
conducted	using	15	adult	lactating	Holstein	dairy	
cows	from	the	same	farm.	The	 farm	is	 located	 in	
Al-Dulail	City	in	the	Northern	East	of	Jordan.	The	
study	was	conducted	during	the	summer	of	2015	
between	 the	 months	 of	 April	 and	 August.	 The	
weather	in	this	part	of	Jordan	is	characterized	by	
long	and	hot	dry	summers	(May	to	October)	and	
windy,	cold	winters.	The	average	temperatures	can	
vary	between	-1Co	to	37Co	and	the	yearly	average	
rainfall	is	typically	less	than	200mm.	There	are	500	
lactating	Holstein	dairy	cows	 in	 the	 farm	housed	
freely	in	open	sheds.	The	cows	are	fed	3	times	per	
day	a	total	mixed	ration	with	ad lib	of	fresh	water.	
The	cows	are	milked	3	times	per	day	in	a	double	
32-cow	 herringbone-milking	 parlor.	 Cows	 were	
selected	for	the	study	based	on	a	clinical	diagnosis	
of	bloody	milk	at	any	stage	of	lactation.		
Clinical examination and sample collection
Only	 cows	 with	 hemolactia	 not	 associated	
with	 physiologic	 udder	 edema	 were	 selected	
for	 this	 study.	 Selected	 cows	 were	 subjected	 to	
a	 complete	 physical	 examination	 on	 the	 farm	
either	 by	 the	 principle	 investigator	 or	 by	 the	
farm	veterinarian.	From	each	cow,	a	whole	blood	
sample	was	collected	via	coccygeal	vein	puncture.	
Collected	 blood	was	 divided	 into	 3	 portions	 and	
placed	in	EDTA	and	Citrate-	containing	tubes	and	
in	 plain	 tubes.	 Sterile	 milk	 samples	 were	 also	
collected	and	placed	in	sterile	tubes	for	bacterial	
culture	and	sensitivity	testing.	To	assess	the	effect	
of	 formalin	 intravenous	 injection	 on	 various	
parameters,	blood	and	milk	samples	were	retaken	
7	 days	 after	 the	 last	 injection.	 For	 comparison,	
whole	blood	samples	were	also	collected	from	10	
normal	cows	in	a	similar	stage	of	lactation.
Drug preparation and injection
Cows	 were	 grouped	 into	 formalin-treated	
(n=15)	and	non-formalin-treated	(n=10)	cows	and	
used	as	control.	In	the	formalin-treated	cows,	500	
milliliters	 of	 0.37%	 formaldehyde	 solution	 were	
administered	intravenously.	Non	formalin-treated	
cows	 were	 not	 administered	 any	 medication	
and	 were	 left	 to	 self-cure.	 To	 make	 the	 desired	
solution,	 a	 5-ml	 of	 37%	 formaldehyde	 solution	
(Chemanol,	Saudi	Arabia)	was	added	into	500-ml	
sterile	saline.	Formaldehyde	was	passed	through	a	
0.2µm	single	use	Ministart	filter	(Sigma,	Germany)	
to	 make	 the	 solution	 ready	 for	 intravenous	
administration.	 Intravenous	 administration	 was	
then	 accomplished	 by	 injecting	 the	 drug	 via	 the	
jugular	 vein	 using	 IV	 catheter	 (Angiocath,	 16GA	
X	 5.25”,	 Medline	 Industries,	 Illinois,	 USA)	 over	
5	 minutes	 period.	 Cows	 were	 administered	 the	
drug	once	a	day	until	cure	was	achieved	or	 for	a	
maximum	 of	 5	 to	 7	 injections.	 Normal	 control	
cows	were	not	administered	any	drugs.
Adjunctive treatments
Randomly	 selected	 cows	 in	 the	 formalin-
treated	group	were	administered	additionally	400-
ml	of	calcium	borogluconate	11.88g	intravenously	
(Calciject	 40,	 Norbrook,	 Northamptonshire,	 UK)	
and	one	dose	of	Vitamin	K1	(Neogen	Corporation,	
Lexington,	 Kentucky,	 USA)	 at	 2.5	 mg/kg	 intra-
muscularly	as	an	adjunctive	treatment	on	day	1.	
Safety and behavioral effects
The	 safety	 of	 the	 drug	 was	 evaluated	 by	
monitoring	 physical	 examination	 parameters;	
temperature,	 heart	 rate,	 respiratory	 rate,	 mucus	
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membrane	 color,	 capillary	 refill	 time,	 rumen	
motility,	and	any	abnormal	behavior	or	activity	of	
the	cow	 like	 salivation,	urination	and	defecation,	
tremors	 etc..	 To	 assess	 the	 long-term	 effects,	 all	
cows	 were	 clinically	 examined	 and	 whole	 blood	
and	milk	samples	were	recollected	again	at	1	week	
after	 the	 last	 injection.	 Furthermore,	 the	 health	
status	of	all	cows	was	followed-up	for	12	months.
Hematology and serum biochemical 
analyses 
The	 total	white	 blood	 cell	 count	 (WBC),	 red	
blood	cell	count	(RBC),	hemoglobin	concentration	
(Hb),	packed	cell	volume	(PCV),	mean	corpuscular	
volume	 (MCV),	 mean	 corpuscular	 hemoglobin	
concentration	 (MCHC)and	 platelets	 count	 were	
determined	 using	 an	 electric	 cell	 counter	 (ABC	
Vet	 hematology	 analyzer,	 ABX	 Diagnostics,	
Maizy,	 France).	 Fibrinogen	 concentrations	 were	
determined	 using	 heat-precipitation	 method	
(Thrall,	2004).
Serum	 was	 obtained	 by	 centrifugation	 of	
clotted	 blood	 samples	 at	 1500g	 for	 10	 minutes.	
Serum	then	was	analyzed	using	routine	methods	
including	 total	 protein,	 blood	 urea	 nitrogen,	
creatinine,	aspartate	aminotransferase	(AST),	ala-
nine	aminotransferase	(ALT),	alkaline	phosphatase	
(ALP),	calcium,	sodium,	chloride	and	potassium.
Clotting factors determination
Whole	 blood	 in	 Citrate-containing	 tubes	
was	 used	 to	 determine	 the	 following	 clotting	
parameters:	 activated	 partial	 thromboplastin	
time	 (APTT)	 (STA-	 C.K.	 Prest,	 Stago,	 France),	
prothrombin	time	(PT)	(Néoplastine	CI	Plus,	Stago	
France),	 thrombin	 time	 (TT)	 (STA	 –Thrombin,	
Stago,	 France),	 and	 D-Dimers	 (D-Di	 Test,	 Stago,	
France).	 Laboratory	 analyses	 were	 performed	
within	2	hours	3	hours	of	sample	collection.
Milk culture and antimicrobial sensitivity 
testing
Individual	 milk	 samples	 from	 affected	 cows	
were	 obtained	 from	 each	 quarter	 aseptically,	
placed	 in	 sterile	 tubes,	 and	 sent	 for	 bacterial	
culture	and	antibacterial	sensitivity	testing	using	
routine	methods	(Oliver	et al.,	2004).	
Statistical analysis
Data	 was	 presented	 as	 mean	 ±	 standard	
deviation.	 Repeated	 measure	 analysis	 of	 each	
of	 the	 evaluated	 variables	 was	 performed	 using	
GLM	 repeated	 measures.	 Post-hoc	 pairwise	
comparisons	 were	 performed	 using	 Bonferroni	
test.	 Differences	 were	 considered	 statistically	
significant	 if	 the	 P	 ≤	 0.05.	 The	 analysis	 was	
conducted	using	statistical	software	(SPSS,	Version	
19.0,	SPSS	Inc,	Chicago,	USA).
RESULTS AND DISCUSSION
Animals and initial clinical examination 
findings
There	were	25	cows	(60	quarters)	presented	
to	the	sick	pen	on	the	farm	for	evaluation	of	bloody	
milk.	 Fifteen	 of	 those	 cows	 (32	 quarters)	 were	
administered	 formalin	 while	 the	 rest	 were	 not	
treated	 and	 used	 as	 control.	 The	 average	 parity	
and	 days	 in	 milk	 (DIM)	 of	 the	 formalin-treated	
cows	 were	 2.3,	 and	 124	 respectively	 (Tab.	 1).	
There	were	eight	open	cows	and	seven	pregnant	
cows	in	different	stages	of	pregnancy	(Tab.	1).	In	
the	non	formalin-treated	cows,	the	average	parity	
and	DIM	were	3	and	150	respectively.	Three	cows	
were	pregnant.	
Physical	 examination	 of	 the	 affected	 cows	
revealed	normal	temperature,	heart	rate,	respira-
tory	 rate,	mucus	membrane	 color,	 capillary	 refill	
time,	 and	 rumen	 motility.	 Examination	 of	 the	
udder	 revealed	mild	 to	moderate	 swelling	of	 the	
affected	 quarter.	 In	 the	 formalin-treated	 cows,	
there	were	eight	cows	affected	 in	only	1	quarter,	
two	cows	in	2	quarters	and	five	cows	in	4	quarters.	
In	the	non	formalin-treated	group,	there	were	two	
cows	affected	in	1	quarter,	two	cows	affected	in	2	
quarters,	2	cows	affect	in	3	quarters	and	four	cows	
affected	in	4	quarters.	The	color	of	milk	secretion	
ranged	 from	 blood-tinged	 to	 frank	 blood	 that	
is	 dark	 red	 to	 chocolate-like	 (Fig.	 1).	Blood	 clots	
were	not	seen.	There	were	no	other	abnormalities	
involving	 any	 other	 body	 system	 in	 any	 of	 the	
affected	cows.	
Therapeutic efficacy 
Twenty-six	 out	 the	 32	 quarters	 (81.25%)	
were	cured	completely	after	intravenous	formalin	
injection	 (Tab.	 2).	 The	 average	 days	 to	 complete	
cure	in	the	treated	cows	was	4	days.		Out	of	the	26	
cured	quarters,	20	belonged	to	cows	that	received	
only	 formalin	 while	 the	 remaining	 6	 quarters	
belonged	 to	 cows	 that	 received	 formalin	 in	
addition	to	calcium	borogluconate	and	vitamin	K1	
as	an	adjunctive	treatment.	Staphylococcus aureus 
was	 isolated	 from	milk	 samples	 of	 four	 cows,	 3	
of	 them	 were	 cured	 after	 the	 administration	 of	
formalin	and	adjunctive	treatments	and	the	fourth	
cow	was	cured	after	the	administration	of	formalin	
only.	None	of	these	cows	was	administered	local	or	
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systemic	antibiotics.	In	the	non	treated-cows,	out	
of	28	affected	quarters,	only	15	were	self-cured	in	
an	average	of	7	to	8	days.	Five	quarters	were	cured	
in	 13	 to	 15	 days	 and	 8	 quarters	were	 not	 cured	
at	 all.	 Milk	 sample	 culture	 revealed	 no	 bacterial	
growth	in	any	of	the	control	cows.
Safety and behavioral effects
All	 cows	 appeared	 to	 tolerate	multiple,	 once	
per	day	intravenous	injection	of	500-ml	of	0.37%	
formaldehyde	 solution.	 The	 rectal	 temperature,	
heart	 rate,	 respiration	 rate,	 mucus	 membrane	
color,	 capillary	 refill	 time	 and	 rumen	 motility	
patterns	were	not	changed	significantly	(data	not	
shown)	 during	 or	 immediately	 after	 injection.	
There	 were	 no	 abnormal	 clinical	 signs	 such	 as	
salivation,	 urination,	 defecation,	 tremors	 or	 any	
other	nervous	signs	or	abnormal	behaviors.	None	
of	 the	 pregnant	 cows	 aborted	 immediately	 or	
during	 the	 following	 6-12	 months	 of	 follow-up	
period.
Hematology and serum biochemical 
analyses
Hematology	and	serum	biochemical	analyses	
in	 Holstein	 dairy	 cows	 before	 and	 1	 week	 after	
the	 last	 intravenous	 administration	 of	 500-ml	 of	
0.37%	formaldehyde	solution	once	per	day	for	2-7	
injections	are	presented	in	Tables	3	and	4.	There	
were	no	statistically	significant	changes	in	any	of	
the	measured	parameters.
Clotting factors
Tab.	 5	 shows	 the	 results	 of	 various	 clotting	
factors	 in	 control	 and	 treated	 cows	 before	 and	
BANI	ISMAIL	et al
Fig. 1.	Bloody	milk	secretion	in	a	Holstein	dairy	cow	treated	with	intravenous	injection	of	
500-ml	of	0.37%	formaldehyde	solution.	
Tab. 1.	Some	epidemiological	information	of	15	Holstein	dairy	cows	affected	with	hemolactia.
Cow	number Parity Days	in	milk	(DIM) Reproductive	status
1 2 72 Open
2 3 150 1	month	pregnant
3 3 160 Open
4 1 150 Open
5 2 260 7	months	pregnant
6 3 120 2	month	pregnant
7 2 180 5	months	pregnant
8 2 300 5	months	pregnant
9 2 180 7	months	pregnant
10 2 12 Open
11 3 8 Open
12 1 157 4	months	pregnant
13 3 1 Open
14 1 10 Open
15 3 100 																	Open
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1	 week	 after	 the	 intravenous	 administration	 of	
500-ml	of	0.37%	formaldehyde	solution	once	per	
day	 for	 2-7	 injections.	 There	were	 no	 significant	
differences	in	any	of	the	parameters	when	it	was	
compared	 between	 the	 normal	 cows	 and	 the	
values	 in	 treated	cows	before	 the	administration	
of	 the	 drug.	 However,	 when	 comparisons	 were	
made	in	treated	cows	between	those	values	before	
and	1	week	after	drug	administration,	a	significant	
difference	 could	be	noticed	 in	platelets	numbers	
and	 APTT	 values.	 Platelets	 numbers	 were	
significantly	increased	in	the	post	administration	
period,	while	the	value	of	APPT	was	significantly	
decreased.
In	 this	 study,	 bloody	milk	 was	 diagnosed	 in	
25	cows	(60	quarters),	some	of	them	were	heifers	
while	 others	 were	 adult	 cows.	 All	 cows	 were	 in	
variable	stages	of	lactation	when	the	problem	was	
diagnosed	but	none	of	them	was	fresh	or	suffering	
from	 physiologic	 udder	 edema.	 Therefore,	 the	
exact	cause	of	the	problem	in	this	herd	was	difficult	
to	 ascertain.	 The	 fact	 that	 only	 1	 or	 2	 quarters	
were	 affected	 in	 most	 of	 the	 cows	may	 indicate	
udder	trauma	may	be	considered	as	the	cause	of	
the	problem.	
Previous	 researchers	 have	 suggested	 that	
local	 or	 systemic	 infections	 such	 as	 mastitis	 or	
leptospirosis	 could	 be	 the	 cause	 of	 bloody	 milk	
in	 some	 herds	 (George	 et al.,	 2008;	 Radostits	 et 
al.,	 2007).	 Although,	 in	 this	 study,	 milk	 culture	
revealed	 Staphylococcus aureus	 in	 four	 cows,	 it	
was	 impossible	 to	claim	that	 this	microorganism	
was	 the	 cause	 of	 bloody	 milk	 in	 those	 cows.	 It	
is	 interesting,	 however	 to	 notice	 that	 all	 cows	
from	 which	 Staphylococcus aureus	 was	 isolated	
completely,	 clinically	 and	 bacteriologically	 cured	
without	 the	 administration	 of	 either	 systemic	
or	 intramammary	 antibiotics.	 This	 could	 be	
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Tab. 2.	Clinical	and	microbiological	findings,	treatment	regimens	and	outcome	of	15	Holstein	dairy	
cows	affected	with	hemolactia.
Cow	
number
Number	of	
quarters	
affected
Milk	culture	
results
Number	of	
formalin	doses	
administered
Adjunctive	treatments
Treatment	
outcome
1 1 Negative 3 None Cured
2 1 Negative 3
Calcium	borogluconate	11.88g	IV	
once;	Vitamin	K1	2.5mg/kg	IM	once
Cured
3 2
Staphylococcus	
aureus
3
Calcium	borogluconate	11.88g	IV	
once;	Vitamin	K1	2.5	mg/kg	IM	once
Cured
4 1
Staphylococcus	
aureus
3
Calcium	borogluconate	11.88g	IV	
once;	Vitamin	K1	2.5mg/kg	IM	once
Cured
5 1 Negative 3
Calcium	borogluconate	11.88g	IV	
once;	Vitamin	K1	2.5mg/kg	IM	once
Cured
6 4 Negative 5 None Cured
7 2 Negative 5 None
1	quarter	
not	cured
8 1
Staphylococcus	
aureus
6
Calcium	borogluconate	11.88g	IV	
once;	Vitamin	K1	2.5mg/kg	IM	once
Cured
9 4 Negative 2 None Cured
10 1 Negative 5 None Cured
11 1 Negative 5 None Cured
12 1 Negative 5 None Cured
13 4
Staphylococcus	
aureus
5 None
Cured
14 4 Negative 5
Calcium	borogluconate	11.88g	IV	
once;	Vitamin	K1	2.5mg/kg	IM	once
4	quarters	
not	cured
15 4 Negative 7 None
1	quarter	
not	cured
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explained	 by	 incidental	 isolation	 of	 the	 bacteria	
from	intermittent	shedders	 in	cows	with	chronic	
subclinical	infections.
Although,	 milk	 samples	 were	 not	 cultured	
for	 Leptospira spp.,	 we	 do	 not	 believe	 that	 this	
microorganism	 could	 have	 contributed	 to	 the	
problem	 in	 this	herd.	 In	cows	with	 leptospirosis,	
usually	the	4	quarters	are	affected	(George	et al.,	
2008;	Radostits	et al.,	 2007).	 The	bloody	milk	 is	
usually	thick	with	blood	and	milk	clots	are	present	
(George	 et al.,	 2008;	 Radostits	 et al.,	 2007).	 The	
affected	 udders	 are	 usually	 flaccid	 and	 affected	
cows	 commonly	 experience	 other	 clinical	 signs	
such	 as	 fever,	 hemoglobinuria,	 abortion,	 and	
decrease	 in	 appetite	 and	 milk	 yield	 (George	 et 
al.,	 2008;	 Radostits	 et al.,	 2007).	 None	 of	 these	
signs	 was	 present	 in	 the	 cows	 in	 this	 study.	
Moreover,	 careful	 environmental	 investigation	
and	 examination	 of	 the	 diet	 in	 this	 herd	 could	
not	 locate	 any	 toxic	 plants	 and	 the	 hematology	
evaluation	 has	 ruled	 out	 thrombocytopenia	 as	 a	
possible	cause.	
Traditional	 treatments	 in	 cows	 with	 bloody	
milk	 include	 injection	 of	 calcium	 solutions,	
parenteral	 coagulants	 (Adrenochrome	 monose-
micarbazone,	 or	 Tranexamic	 acid)	 and	 intra-
mammary	 coagulants	 (Thrombonar)	 (George	 et 
al.,	2008;	Muhammad	et al.,	1997;	Radostits	et al.,	
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Tab. 4.	Mean	±	SD	of	certain	serum	biochemical	analyses	parameters	 in	15	Holstein	dairy	cows	
affected	with	hemolactia	before	and	after	the	intravenous	injection	of	500-ml	0.37%	formalin	
solution.
Parameter Normal	(n=10) Control	(n=10)
Treated	cows	(n=15)
Before	
administration
1	week	after	last	
administration
AST	(U/L)	 88±30 98±15 50±17 62±17
ALT	(U/L) 40±14 42±11 30±10 30±5.0
ALP	(U/L) 96±13 110±19 75±80 227±115*
Total	protein	(g/L) 77±12 85±8 85±14 70±14
BUN	(mmol/L) 3.2±3.0 4.0±2.0 3.7±2.5 3.8±1.8
Creatinine	(µmol/L) 56±6.0 66±3.0 55±10 60±5.0
Calcium	(mmol/L) 3.0±0.7 3.5±0.5 2.8±0.5 2.9±0.5
Sodium	(mmol/L) 140±10 141±2 141±4.5 144±1.4
Chloride	(mmol/L) 103±5.0 102±5.0 101±0.90 104±2.5
Potassium	(mmol/L) 5.5±5.0 4.9±5.0 6.0±1.0 6.8±1.2
*	P	≤	0.05
AST-	aspartate	aminotransferase,	ALT-	alanine	aminotransferase,	ALP-	alkaline	phosphatase,	BUN-	blood	urea	nitrogen.
Tab. 3.	 Mean	 ±	 SD	 of	 certain	 hematology	 parameters	 in	 15	 Holstein	 dairy	 cows	 affected	 with	
hemolactia	before	and	after	the	intravenous	injection	of	500-ml	0.37%	formalin	solution.
Parameter Normal		(n=10) Control	(n=10)
Treated	cows	(n=15)
Before	
administration
1	week	after	last	
administration
WBC	(×103	cells/µl) 10±2.0 9±1.5 10.3±2.0 11.5±2.5
RBC	(x106	cells/µl) 7.0±0.5 75.0±0.5 7.2±0.7 6.5±1.3
Hb	(g/dl) 11±1.3 10±1.0 11±1.2 10±1.0
PCV% 28±2.5 30±2.0 34±4.0 32±4.0
MCV	(fl) 47±5.0 51±3.0 47±4.5 52±5.0
MCH(	pg) 14±2.0 13±2.5 14±1.2 15±2.5
MCHC	(g/dl) 30±1.5 31±1.5 31±0.1 30±0.6
WBC-	white	blood	cell	count,	RBC-	red	blood	cell	count,	Hb-	hemoglobin	concentration,	PCV-	packed	cell	volume,	MCV-	mean	corpuscular	
volume,	MCHC-	mean	corpuscular	hemoglobin	concentration.
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2007).	However,	some	of	these	treatments	are	not	
always	available,	expensive	and	most	importantly	
lack	the	clinical	and	experimental	data	to	support	
their	safety	and	efficacy.	Therefore,	an	innovative,	
effective	 and	 yet	 cheap	 and	 safe	 alternative	
treatment	is	still	warranted.	
Formalin	has	been	widely	used	in	laboratories	
as	 a	 preservative,	 tissue	 fixative,	 disinfectant	
and	 embalming	 agent	 for	 many	 years	 (EFSA,	
2004).	 Recent	 medical	 reports	 in	 dogs,	 horses	
and	 human	medicine	 have	 indicated	 a	 beneficial	
effect	of	using	formalin	to	control	hemorrhage.	It	
was	 suggested	 that	 formalin	 enhances	 primary	
hemostasis	 through	 enhancing	 endothelial	 or	
platelet	 activation	 mechanisms	 (Choong	 et al.,	
2000;	Mathai	et al.,	1995;	Henrikson	et al.,	2004;	
Kang	 et al.,	 2003;	 Lee	 et al.,	 2007;	 Mohamed	 et 
al.,	 2012).	 In	 this	 study,	 platelets	 numbers	were	
significantly	increased	after	the	administration	of	
the	drug	while	only	APTT	values	were	significantly	
decreased	in	treated	cows.
In	this	study,	almost	81%	of	affected	quarters	
were	 completely	 cured	 after	 2	 to	 7	 once	 per	
day	 injections	 of	 formalin.	 Although	 in	 human	
beings	with	urinary	bladder	 and	 rectal	 bleeding,	
formalin	has	been	used	by	topical	or	intralesional	
application,	 the	 use	 of	 formalin	 intravenously	 in	
cattle	presents	quick	and	easy	way	to	administer	
in	 field	 situations.	 The	 success	 rate	 of	 using	
formalin	 for	 intractable	 hemorrhage	 in	 human	
beings	 is	 reportedly	 around	 70-92%	 (Choong	 et 
al.,	2000)	which	is	similar	to	the	results	reported	
here	(81%).
Formaldehyde	 is	 considered	 toxic	 and	
carcinogenic	 naturally	 occurring	 substance	
(EFSA,	 2004).	 Local	 toxic	 effects	 of	 formalin	
have	 been	 reported	 in	 some	 human	 patients	
including	 contracted	 urinary	 bladder,	 urinary	
incontinence,	 ureteral	 stenosis	 and	 obstruction,	
hydroureteronephrosis,	renal	damage	and	rupture	
of	the	bladder	(Choong	et al.,	2000).	In	this	study,	
we	used	 intravenous	 formalin	 injection	 in	a	very	
low	 concentration	 based	 on	 previous	 studies	 in	
horses	 (Taylor	 et al.,	 2000).	 Larger	 volumes	 and	
higher	concentrations	of	 formalin	 in	horses	have	
been	 reported	 to	 cause	 mild	 to	 moderate	 toxic	
signs	(Taylor	et al.,	2000).	In	this	study,	there	were	
no	 abnormal	 clinical	 signs	 associated	 with	 the	
intravenous	injection	of	500-ml	of	0.37%	solution	
of	 formaldehyde.	 In	 addition,	 the	 hematology	
and	 serum	 biochemical	 analyses	 revealed	 no	
significant	 changes	 that	 may	 indicate	 systemic	
toxicity.	
Although	 formalin	 residues	 in	 milk	 were	
not	 measured	 in	 this	 study,	 endogenous	
background	formalin	levels	in	meat	and	milk	and	
formalin	 levels	 in	 cows’	 milk,	 blood	 and	 tissues	
fed	 formalin-treated	 whey	 were	 determined	
previously	and	found	below	the	determined	toxic	
levels	in	human	beings	(Buckley et al.,	1988;	EFSA,	
2004).	Nevertheless,	future	research	is	warranted	
to	 determine	 acceptable	 levels	 of	 formalin	 in	
milk	 and	 meat	 of	 dairy	 cows	 after	 intravenous	
administration	of	this	drug.
Successful	Treatment	of	Bloody	Milk	Not	Associated	With	Physiologic	Udder	Edema	in	Lactating	Holstein	Cows
Tab. 5. Mean	±	SD	of	platelets	numbers,	fibrinogen	concentration,	and	certain	clotting	factors	
in	 15	 Holstein	 dairy	 cows	 affected	 with	 hemolactia	 before	 and	 after	 the	 intravenous	
injection	of	500-ml	0.37%	formalin	solution.
Parameter
Normal	cows	
(n=10)
Control	cows	
(n=10)
Treated	cows	(n=15)
Before	
administration
1	week	after	last	
administration
Platelet	(x103	cells/µL) 370±130 350±110 330±170 550±120*
PT	(seconds) 29±0.5 30±0.5 27±2.0 27±4.0
APTT	(seconds) 56±7.0 55±7.0 60±10 47±10*
TT	(seconds) 29±3.0 28±3.0 27±5 30±6.0
D-dimer	(ng/ml)	 <0.5 <0.5 <0.5 <0.5
Fibrinogen	(mg/dL) 600±200 550±200 750±150 675±250
*	P	≤	0.05
PT-	prothrombin	time,	APTT-	activated	partial	thromboplastin	time,	TT-		thrombin	time.
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CONCLUSION  
Results	 of	 this	 study	 prove	 an	 effective	
and	 safe,	 widely	 available	 and	 cheap	 treatment	
for	 dairy	 cows	 affected	 with	 bloody	 milk	 not	
associated	with	physiologic	udder	edema	in	one	or	
more	quarters.	This	innovative	treatment	is	once	
per	day	 intravenous	 administration	of	500-ml	of	
0.37%	 formaldehyde	 solution	 with	 or	 without	
intravenous	 calcium	 solutions	 or	 intramuscular	
vitamin	K	injections.
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